Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis

INTRODUCTION: Erenumab, a fully human monoclonal antibody against the calcitonin gene-related peptide receptor, is approved in Japan for the prevention of adult migraine. This post-hoc analysis evaluated the efficacy of erenumab in Japanese patients with low-frequency episodic migraine (LFEM) versus...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitamura, Shigekazu, Takeshima, Takao, Yui, Daishi, da Silva Lima, Gabriel Paiva, Koukakis, Reija, Peng, Cheng, Yoshida, Ryuji, Numachi, Yotaro, Hasebe, Miki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630255/
https://www.ncbi.nlm.nih.gov/pubmed/37698837
http://dx.doi.org/10.1007/s40120-023-00538-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630255/
https://www.ncbi.nlm.nih.gov/pubmed/37698837
http://dx.doi.org/10.1007/s40120-023-00538-w

Ejemplares similares